PubRank

Mesenchymal to epithelial transition in sarcomas.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMID 24291235)

Published in Eur J Cancer on November 28, 2013

Authors

Jilong Yang1, Xiaoling Du2, Guowen Wang3, Yan Sun4, Kexin Chen5, Xiongzeng Zhu6, Alexander J F Lazar7, Kelly K Hunt8, Raphael E Pollock9, Wei Zhang10

Author Affiliations

1: Department of Bone and Soft Tissue Tumors, National Clinical Cancer Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China. Electronic address: yangjilong@tjmuch.com.
2: Department of Diagnostics, Tianjin Medical University, Tianjin 300060, China. Electronic address: xiaolingdu2003@163.com.
3: Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China. Electronic address: wgwhrb@126.com.
4: Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China. Electronic address: sunyan@tjmuch.com.
5: Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China. Electronic address: chenkexin1963@yahoo.com.
6: Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Electronic address: xiongzengzhu@163.com.
7: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: alazar@mdanderson.org.
8: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: khunt@mdanderson.org.
9: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: rpollock@mdanderson.org.
10: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: wzhang@mdanderson.org.

Articles citing this ↘

A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Genes Chromosomes Cancer (2014) 0.84

Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells. Mol Clin Oncol (2014) 0.79

YB-1 regulates tiRNA-induced Stress Granule formation but not translational repression. Nucleic Acids Res (2016) 0.78

Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma. Neoplasia (2016) 0.75

Mitochondrial DNA plasticity is an essential inducer of tumorigenesis. Cell Death Discov (2016) 0.75

Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity. PLoS One (2016) 0.75

cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death Dis (2017) 0.75

Microvessels Density in Uterine Leiomyosarcoma. Biomed Res Int (2015) 0.75

Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study. Oncol Lett (2017) 0.75

Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells. PLoS One (2017) 0.75

BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells. Oncotarget (2017) 0.75

Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis. Oncogene (2017) 0.75

SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters. Nat Genet (2017) 0.75

Articles by these authors ⇆

Clonality: A New Marker for Gastric Cancer Survival. J Genet Genomics (2015) 0.75